U.S. COVID vaccines start to roll out for young children
Reuters
Published Jun 21, 2022 09:42AM ET
Updated Jun 22, 2022 03:57AM ET
By Leroy Leo
(Reuters) - The United States has begun distributing COVID vaccines for children as young as six months around the country, and availability of the shots will improve in the coming days, according to White House COVID-19 response coordinator Dr. Ashish Jha.
U.S. regulators authorized Moderna (NASDAQ:MRNA) Inc's two-dose vaccine for children aged six months to five years and the Pfizer-BioNTech three-shot regimen for children aged six months to four years late last week.
It is unclear how many parents will vaccinate their youngest children.
Just one-in-five parents with children under age five said they intended to vaccinate them "right away" after they become eligible, a survey by the Kaiser Family Foundation published in May showed. Only about 29% of children aged five to 11 have been fully vaccinated with the Pfizer-BioNTech vaccine since it was authorized in October, according to U.S. data.
Chinmay Hegde, father of a 14-month old daughter, told Reuters outside Children's National Hospital in Washington that the U.S. authorization was a huge relief. His daughter was the first to be vaccinated at the hospital on Tuesday.
"I feel like we can just now go travel and do our trips without feeling as much stress," he said, mentioning a planned family reunion in Canada in July.
Children who begin their vaccinations with the Pfizer (NYSE:PFE) shot this week could receive their third dose the week of Sept. 12 or later. Those who receive a first Moderna shot this week could complete their inoculation as soon as July 19.
Dr. Celine Gounder, an infectious disease specialist and editor-at-large for Public Health at Kaiser Health News, said parents will need to consider a trade-off between the number of shots and risk of side-effects.
Moderna's vaccine uses a larger dose and has a higher likelihood of inducing fever than Pfizer's.
"These are not dangerous side effects and they are manageable with medications like acetaminophen," said Gounder, a former member of President Joe Biden's COVID transition team.
But some parents may feel like "'well, even if it's a three-dose vaccine, it will minimize the risk of fever,'" she said.
Jha said on Twitter (NYSE:TWTR) on Monday that the rollout for younger children differed from those for other age groups in that there were no mass vaccination sites, but there would be more inoculations done in doctors' offices.
"Parents are clear they want to vaccinate their littlest ones in familiar settings - doctors offices, pharmacies, health clinics, and children's hospitals," he tweeted.
Get The News You Want
The vaccines began shipping on Friday and Saturday, Jha said, adding that more doctors' offices and hospitals would begin receiving them on Tuesday and Wednesday of this week.
Not all pharmacies will offer the shots to everyone in this age group. CVS Health Corp (NYSE:CVS) will offer shots for children aged 18 months and up, while Walmart (NYSE:WMT) Inc and Rite Aid (NYSE:RAD) Corp will offer them to those aged 3 and older.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.